Cytotoxicity of albebetin oligomers depends on cross-beta-sheet formation.
Identifieur interne : 002259 ( PubMed/Corpus ); précédent : 002258; suivant : 002260Cytotoxicity of albebetin oligomers depends on cross-beta-sheet formation.
Auteurs : Vladimir Zamotin ; Anna Gharibyan ; Natalia V. Gibanova ; Marika A. Lavrikova ; Dmitry A. Dolgikh ; Michail P. Kirpichnikov ; Irina A. Kostanyan ; Ludmilla A. Morozova-RocheSource :
- FEBS letters [ 0014-5793 ] ; 2006.
English descriptors
- KwdEn :
- Amyloid (metabolism), Animals, Biopolymers (chemistry), Biopolymers (toxicity), Cells, Cultured, Cerebellum (cytology), Cerebellum (drug effects), Cerebellum (metabolism), Circular Dichroism, Male, Microscopy, Atomic Force, Neurons (drug effects), Neurons (metabolism), Proteins (chemistry), Proteins (toxicity), Rats, Rats, Wistar, Recombinant Proteins (chemistry), Recombinant Proteins (toxicity), Spectrophotometry, Ultraviolet.
- MESH :
- chemical , chemistry : Biopolymers, Proteins, Recombinant Proteins.
- chemical , metabolism : Amyloid.
- chemical , toxicity : Biopolymers, Proteins, Recombinant Proteins.
- cytology : Cerebellum.
- drug effects : Cerebellum, Neurons.
- metabolism : Cerebellum, Neurons.
- Animals, Cells, Cultured, Circular Dichroism, Male, Microscopy, Atomic Force, Rats, Rats, Wistar, Spectrophotometry, Ultraviolet.
Abstract
Prefibrillar cytotoxicity was suggested as a common amyloid characteristic. We showed two types of albebetin prefibrillar oligomers are formed during incubation at pH 7.3. Initial round-shaped oligomers consist of 10-15 molecules determined by atomic force microscopy, do not bind thioflavin-T and do not affect viability of granular neurons and SH-SY5Y cells. They are converted into ca. 30-40-mers possessing cross-beta-sheet and reducing viability of neuronal cells. Neither monomers nor fibrils possess cytotoxicity. We suggest that oligomeric size is important for stabilising cross-beta-sheet core critical for cytotoxicity. As albebetin was used as a carrier-protein for drug delivery, examination of amyloidogenicity is required prior polypeptide biomedical applications.
DOI: 10.1016/j.febslet.2006.03.074
PubMed: 16638570
Links to Exploration step
pubmed:16638570Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cytotoxicity of albebetin oligomers depends on cross-beta-sheet formation.</title>
<author><name sortKey="Zamotin, Vladimir" sort="Zamotin, Vladimir" uniqKey="Zamotin V" first="Vladimir" last="Zamotin">Vladimir Zamotin</name>
<affiliation><nlm:affiliation>Department of Medical Biochemistry and Biophysics, Umeå University, SE-901 87 Umeå, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gharibyan, Anna" sort="Gharibyan, Anna" uniqKey="Gharibyan A" first="Anna" last="Gharibyan">Anna Gharibyan</name>
</author>
<author><name sortKey="Gibanova, Natalia V" sort="Gibanova, Natalia V" uniqKey="Gibanova N" first="Natalia V" last="Gibanova">Natalia V. Gibanova</name>
</author>
<author><name sortKey="Lavrikova, Marika A" sort="Lavrikova, Marika A" uniqKey="Lavrikova M" first="Marika A" last="Lavrikova">Marika A. Lavrikova</name>
</author>
<author><name sortKey="Dolgikh, Dmitry A" sort="Dolgikh, Dmitry A" uniqKey="Dolgikh D" first="Dmitry A" last="Dolgikh">Dmitry A. Dolgikh</name>
</author>
<author><name sortKey="Kirpichnikov, Michail P" sort="Kirpichnikov, Michail P" uniqKey="Kirpichnikov M" first="Michail P" last="Kirpichnikov">Michail P. Kirpichnikov</name>
</author>
<author><name sortKey="Kostanyan, Irina A" sort="Kostanyan, Irina A" uniqKey="Kostanyan I" first="Irina A" last="Kostanyan">Irina A. Kostanyan</name>
</author>
<author><name sortKey="Morozova Roche, Ludmilla A" sort="Morozova Roche, Ludmilla A" uniqKey="Morozova Roche L" first="Ludmilla A" last="Morozova-Roche">Ludmilla A. Morozova-Roche</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16638570</idno>
<idno type="pmid">16638570</idno>
<idno type="doi">10.1016/j.febslet.2006.03.074</idno>
<idno type="wicri:Area/PubMed/Corpus">002259</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002259</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Cytotoxicity of albebetin oligomers depends on cross-beta-sheet formation.</title>
<author><name sortKey="Zamotin, Vladimir" sort="Zamotin, Vladimir" uniqKey="Zamotin V" first="Vladimir" last="Zamotin">Vladimir Zamotin</name>
<affiliation><nlm:affiliation>Department of Medical Biochemistry and Biophysics, Umeå University, SE-901 87 Umeå, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gharibyan, Anna" sort="Gharibyan, Anna" uniqKey="Gharibyan A" first="Anna" last="Gharibyan">Anna Gharibyan</name>
</author>
<author><name sortKey="Gibanova, Natalia V" sort="Gibanova, Natalia V" uniqKey="Gibanova N" first="Natalia V" last="Gibanova">Natalia V. Gibanova</name>
</author>
<author><name sortKey="Lavrikova, Marika A" sort="Lavrikova, Marika A" uniqKey="Lavrikova M" first="Marika A" last="Lavrikova">Marika A. Lavrikova</name>
</author>
<author><name sortKey="Dolgikh, Dmitry A" sort="Dolgikh, Dmitry A" uniqKey="Dolgikh D" first="Dmitry A" last="Dolgikh">Dmitry A. Dolgikh</name>
</author>
<author><name sortKey="Kirpichnikov, Michail P" sort="Kirpichnikov, Michail P" uniqKey="Kirpichnikov M" first="Michail P" last="Kirpichnikov">Michail P. Kirpichnikov</name>
</author>
<author><name sortKey="Kostanyan, Irina A" sort="Kostanyan, Irina A" uniqKey="Kostanyan I" first="Irina A" last="Kostanyan">Irina A. Kostanyan</name>
</author>
<author><name sortKey="Morozova Roche, Ludmilla A" sort="Morozova Roche, Ludmilla A" uniqKey="Morozova Roche L" first="Ludmilla A" last="Morozova-Roche">Ludmilla A. Morozova-Roche</name>
</author>
</analytic>
<series><title level="j">FEBS letters</title>
<idno type="ISSN">0014-5793</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amyloid (metabolism)</term>
<term>Animals</term>
<term>Biopolymers (chemistry)</term>
<term>Biopolymers (toxicity)</term>
<term>Cells, Cultured</term>
<term>Cerebellum (cytology)</term>
<term>Cerebellum (drug effects)</term>
<term>Cerebellum (metabolism)</term>
<term>Circular Dichroism</term>
<term>Male</term>
<term>Microscopy, Atomic Force</term>
<term>Neurons (drug effects)</term>
<term>Neurons (metabolism)</term>
<term>Proteins (chemistry)</term>
<term>Proteins (toxicity)</term>
<term>Rats</term>
<term>Rats, Wistar</term>
<term>Recombinant Proteins (chemistry)</term>
<term>Recombinant Proteins (toxicity)</term>
<term>Spectrophotometry, Ultraviolet</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Biopolymers</term>
<term>Proteins</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Amyloid</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="toxicity" xml:lang="en"><term>Biopolymers</term>
<term>Proteins</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Cerebellum</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cerebellum</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Cerebellum</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cells, Cultured</term>
<term>Circular Dichroism</term>
<term>Male</term>
<term>Microscopy, Atomic Force</term>
<term>Rats</term>
<term>Rats, Wistar</term>
<term>Spectrophotometry, Ultraviolet</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Prefibrillar cytotoxicity was suggested as a common amyloid characteristic. We showed two types of albebetin prefibrillar oligomers are formed during incubation at pH 7.3. Initial round-shaped oligomers consist of 10-15 molecules determined by atomic force microscopy, do not bind thioflavin-T and do not affect viability of granular neurons and SH-SY5Y cells. They are converted into ca. 30-40-mers possessing cross-beta-sheet and reducing viability of neuronal cells. Neither monomers nor fibrils possess cytotoxicity. We suggest that oligomeric size is important for stabilising cross-beta-sheet core critical for cytotoxicity. As albebetin was used as a carrier-protein for drug delivery, examination of amyloidogenicity is required prior polypeptide biomedical applications.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16638570</PMID>
<DateCompleted><Year>2006</Year>
<Month>05</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised><Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0014-5793</ISSN>
<JournalIssue CitedMedium="Print"><Volume>580</Volume>
<Issue>10</Issue>
<PubDate><Year>2006</Year>
<Month>May</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>FEBS letters</Title>
<ISOAbbreviation>FEBS Lett.</ISOAbbreviation>
</Journal>
<ArticleTitle>Cytotoxicity of albebetin oligomers depends on cross-beta-sheet formation.</ArticleTitle>
<Pagination><MedlinePgn>2451-7</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Prefibrillar cytotoxicity was suggested as a common amyloid characteristic. We showed two types of albebetin prefibrillar oligomers are formed during incubation at pH 7.3. Initial round-shaped oligomers consist of 10-15 molecules determined by atomic force microscopy, do not bind thioflavin-T and do not affect viability of granular neurons and SH-SY5Y cells. They are converted into ca. 30-40-mers possessing cross-beta-sheet and reducing viability of neuronal cells. Neither monomers nor fibrils possess cytotoxicity. We suggest that oligomeric size is important for stabilising cross-beta-sheet core critical for cytotoxicity. As albebetin was used as a carrier-protein for drug delivery, examination of amyloidogenicity is required prior polypeptide biomedical applications.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zamotin</LastName>
<ForeName>Vladimir</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Department of Medical Biochemistry and Biophysics, Umeå University, SE-901 87 Umeå, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gharibyan</LastName>
<ForeName>Anna</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gibanova</LastName>
<ForeName>Natalia V</ForeName>
<Initials>NV</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lavrikova</LastName>
<ForeName>Marika A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Dolgikh</LastName>
<ForeName>Dmitry A</ForeName>
<Initials>DA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kirpichnikov</LastName>
<ForeName>Michail P</ForeName>
<Initials>MP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kostanyan</LastName>
<ForeName>Irina A</ForeName>
<Initials>IA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Morozova-Roche</LastName>
<ForeName>Ludmilla A</ForeName>
<Initials>LA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2006</Year>
<Month>04</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>FEBS Lett</MedlineTA>
<NlmUniqueID>0155157</NlmUniqueID>
<ISSNLinking>0014-5793</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000682">Amyloid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001704">Biopolymers</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>145185-92-8</RegistryNumber>
<NameOfSubstance UI="C074146">albebetin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001704" MajorTopicYN="N">Biopolymers</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002942" MajorTopicYN="N">Circular Dichroism</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018625" MajorTopicYN="N">Microscopy, Atomic Force</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013056" MajorTopicYN="N">Spectrophotometry, Ultraviolet</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year>
<Month>02</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2006</Year>
<Month>03</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2006</Year>
<Month>03</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2006</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>5</Month>
<Day>31</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2006</Year>
<Month>4</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16638570</ArticleId>
<ArticleId IdType="pii">S0014-5793(06)00404-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.febslet.2006.03.074</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002259 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002259 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:16638570 |texte= Cytotoxicity of albebetin oligomers depends on cross-beta-sheet formation. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:16638570" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |